Franklin Resources Inc. Has $2.67 Million Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Franklin Resources Inc. raised its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 14.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 37,637 shares of the company’s stock after purchasing an additional 4,621 shares during the quarter. Franklin Resources Inc.’s holdings in Henry Schein were worth $2,673,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently modified their holdings of the company. ING Groep NV acquired a new stake in Henry Schein in the 3rd quarter valued at $63,226,000. Holocene Advisors LP acquired a new stake in shares of Henry Schein in the 3rd quarter valued at $58,319,000. Thompson Siegel & Walmsley LLC bought a new stake in shares of Henry Schein in the 2nd quarter worth about $46,683,000. Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in shares of Henry Schein during the 3rd quarter worth about $43,740,000. Finally, Southpoint Capital Advisors LP lifted its holdings in Henry Schein by 30.0% during the 3rd quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company’s stock valued at $189,540,000 after purchasing an additional 600,000 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors.

Henry Schein Stock Performance

Shares of NASDAQ:HSIC opened at $70.01 on Thursday. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a 1-year low of $63.67 and a 1-year high of $82.63. The stock has a market capitalization of $8.73 billion, a P/E ratio of 28.81, a P/E/G ratio of 2.31 and a beta of 0.87. The business has a 50-day moving average price of $72.35 and a two-hundred day moving average price of $70.15.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. During the same period in the previous year, the firm posted $1.32 earnings per share. Henry Schein’s revenue for the quarter was up .4% compared to the same quarter last year. Equities analysts predict that Henry Schein, Inc. will post 4.78 earnings per share for the current year.

Analyst Upgrades and Downgrades

HSIC has been the topic of several research analyst reports. Mizuho began coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price objective on the stock. Evercore ISI increased their price target on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. Barrington Research reiterated an “outperform” rating and issued a $82.00 price objective on shares of Henry Schein in a research report on Wednesday, November 6th. Finally, StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Seven analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $78.89.

Insider Transactions at Henry Schein

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the transaction, the chief operating officer now owns 87,706 shares of the company’s stock, valued at approximately $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.14% of the stock is owned by corporate insiders.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.